Close this search box.

Genomics leaning on citizen science for data gathering


Investing in modern tools for ancient problems

Genome Canada is funding the second stage in a citizen science framework that will process metagenomics and metabolomics data sets from the Earth Microbiome Project. The goal is to identify antibiotic resistance genes in metagenome-assembled genomes through crowdsourcing.

Led by Jérôme Waldispühl at McGill University, the team is partnering with Gearbox Studio to further develop an enormous citizen science video game that will provide valuable information, in the form of much needed data sets.

The project, Crowdsourcing the analysis of metagenomic environmental data for antimicrobial resistant genes through a AAA video game, received over $4.5 million as part of a larger $41 million investment made in May 2024.


The Genomic Applications Partnership Program (GAPP) supports industry-facing partnered research projects that address real-world challenges. Designed to accelerate the social and economic impact of genomics, GAPP provides the space for research, innovation and application to thrive collaboratively. GAPP projects address real-world challenges and opportunities through greater collaboration between genomics scientists and the users of genomics research. They aim to stimulate public- and private-sector investment in Canadian genomics technologies, advancing technology uptake in receptors and moving technologies across readiness levels. 

Quick facts

  • Genome Canada’s Genomic Applications Partnership Program (GAPP) is a flagship initiative that recently marked its 10th year and 100th funded project.
    • GAPP leverages world-leading expertise and diversified public-private partnerships to accelerate the adoption of genomics solutions to generate broad economic and societal benefits for Canada
  • Budget 2021 provided $400 million over six years, starting in 2021–22, to support the creation of the Canadian Genomics Strategy to drive further innovation in genomics through commercialization and adoption. This funding included $136.7 million over two years, starting in 2022–23, for programming delivered by Genome Canada to kick-start the new strategy and complement existing genomics research and innovation programming.
  • Since 2000, Genome Canada has leveraged $1.6 billion in federal investment into a total investment of $3.9 billion in R&D including co-funding, supported over 13,784 talented research trainees, and spun-out more than 120 new Canadian companies.

Media contact

Nicola Katz
Director, Communications
Genome Canada
Cell: 613-297-0267